Utomilumab

Tax included
Utomilumab (PF 05082566) is a fully human IgG2 mAb agonist of the T-cell costimulatory receptor 4-1BB/CD137. Utomilumab can be used for the research of relapsed/refractory follicular lymphoma (FL) and other CD20+ non-Hodgkin lymphomas (NHL).
MedChemExpress 
HY-P99056

Data sheet

Size
Multiple sizes
Reactivity
TNF Receptor
Application
COVID-19-immunoregulation
CAS
1417318-27-4